SEARCH

Massachusetts enters Phase 2 of vaccination plan, here’s what you need to know.

While science was crucial to the creation of the COVID-19 vaccine, good old-fashioned trust is key to making the nationwide vaccination effort a success.

With this is mind, the UMass Medical School, in collaboration with the Worcester Department of Health and Human Services, sponsored a webinar Thursday addressing the hesitancy of people in the Latino community to take the COVID-19 vaccine.

Dr. Robert Finberg, of UMass Medical School, answers questions about COVID vaccine rollout, the vaccine supply and variants.

UMass Memorial Health Care President and CEO Dr. Eric Dickson has been named the new chair of the Massachusetts Health & Hospital Association, the Boston hospital advocacy nonprofit announced Friday.

Steve Roach, the interim president of UMass Memorial HealthAlliance-Clinton Hospital, which has its main offices in Leominster, has been named to the position on a permanent basis.

Roach's appointment, which was announced Monday in a staff memo by Doug Brown, the president of UMass Memorial Community Hospitals, also keeps him as president of UMass Memorial's Marlborough Hospital, a position he's held since 2013.

Coronavirus cases have taken an encouraging downward dip in the past week, including in Worcester County and the city of Worcester, but that relatively promising sign was tempered by a more contagious variant found this week in a person who was tested at UMass Memorial Medical Center in Worcester.

Massachusetts is now allowing everyone in Phase 1 to receive their COVID-19 vaccine. For hospitals, that means they can now give shots to everyone on staff.

At UMass Memorial Medical Center in Worcester, Dr. Andrew Karson, the chief medical officer, believes the vaccine is resulting in a reduction of cases among employees.

Massachusetts is rolling back some coronavirus restrictions on Monday. But with the United Kingdom COVID variant in the state, two local doctors say now is not the time to let our guards down.

Taming a ranging pandemic that has already claimed the lives of more than 400,000 Americans lies heavily in the rollout of the long-awaited COVID-19 vaccine — a process that has been slow and arduous since the emergency approval of such jabs in the U.S.